German private equity player SHS said it invested an undisclosed amount in Emerging Implant Technologies and its 3D-printed orthopedic implants.
EIT develops 3D-printed orthopedic devices and implants, sporting a portfolio of spinal fusion cages and patient-specific implants. The Tuttlingen, Germany-based company said it plans to use the investment to expand its manufacturing capabilities internationally, including in the U.S. The company was founded in 2014.
“Our EIT Cellular Titanium implants provide the answer to current challenges in implant design and choice of materials as well the extreme cost pressure in medical technology. The additive manufacturing technology allows us to tackle existing problems with new solutions. Thus we can improve the benefits for patients without increasing costs, which is a clear competitive advantage,” founder & CEO Guntmar Eisen said in prepared remarks. “This ensures a high level of patient satisfaction and excellent clinical results. We are looking forward to pushing ahead with our international growth, especially in the United States, and our product development with our new partner SHS.”
“EIT’s 3D-printed spine implants have already proven their superior functionality many times in practical applications, thus promoting EIT’s growth,” SHS partner Bernhard Schirmers added. “EIT Emerging Implant Technologies’ management team is experienced and successful in the field of spine surgery. As a medical technology investor, we look forward to supporting them on their path to increased growth.”
